Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Pravastatin Sodium: From Mechanism to Translation
2026-09-07
Pravastatin sodium is more than a conventional HMG-CoA reductase inhibitor: it is a mechanistically defined tool for connecting cholesterol biosynthesis inhibition, LDL cholesterol reduction, transporter biology, and translational safety. This article outlines how researchers can move from enzyme potency to cellular validation and clinically relevant study design.
-
Atrial Natriuretic Peptide (ANP), Rat: Evidence Guide
2026-09-05
Atrial Natriuretic Peptide is a cardiac ANP peptide hormone that supports vasodilation, natriuresis, and blood pressure homeostasis through natriuretic peptide receptor signaling. This guide distinguishes the A1009 ANP 1-11 research material from full-length 28-residue ANP and separates cardiovascular evidence from adiponectin findings.
-
EPI-001: Androgen Receptor N-Terminal Domain Inhibitor
2026-09-04
EPI-001 enables researchers to interrogate androgen receptor signaling beyond conventional ligand-binding-domain blockade, with applications spanning prostate cancer, CRPC models, and selected AR-positive TNBC systems. This workflow-focused guide covers assay design, ARv7-aware controls, formulation, comparative experiments, and troubleshooting.
-
Pentoxifylline: From cAMP to Immune Phenotype
2026-09-04
Pentoxifylline is a phosphodiesterase inhibitor whose cAMP-centered biology links cytokine control with measurable immune phenotypes. This article translates foundational Leishmania and HTLV-1 evidence into a rigorous framework for selecting assays, doses, controls, and translational endpoints.
-
Cholecystokinin octapeptide ammonium: LTP Workflows
2026-09-03
Build receptor-resolved neuroplasticity assays with CCK-8 ammonium, using hippocampal LTP rescue as a practical benchmark. The workflow also shows how to extend the peptide into apoptosis, immune-response, and ANP-secretion studies without confusing biological context or formulation limits.
-
Metal-Chelating L-Phe Nanostructures and ICB
2026-09-03
This Nature Nanotechnology study shows that metal-ion-chelating L-phenylalanine nanostructures can reprogram dendritic-cell electrophysiology and improve immune checkpoint blockade in tumor models. Its central advance is the combination of nanostructure-mediated ion signaling with short-term starvation to enhance uptake, dendritic-cell maturation, and tumor-specific cytotoxic T-cell responses.
-
Cholecystokinin octapeptide ammonium Guide
2026-09-02
A scenario-based guide to using Cholecystokinin octapeptide ammonium (SKU C8717) in viability, proliferation, and cytotoxicity workflows. It covers receptor biology, formulation constraints, concentration selection, controls, interpretation, and practical vendor evaluation.
-
Cinoxacin Workflows for Gram-Negative Research
2026-09-02
Cinoxacin supports structured MIC, disk-diffusion, time-kill, urinary tract infection research, and antibiotic resistance studies focused on susceptible Gram-negative organisms. This workflow guide connects concentration selection, spectrum-aware controls, and longitudinal assay design to help researchers obtain interpretable, reproducible data.
-
CX-4945: CK2, Resistance, and Translation
2026-09-01
CX-4945 (Silmitasertib) offers a mechanistically focused way to investigate how CK2 signaling intersects with tumor cell survival, stemness, therapy resistance, and cell-cycle control. Building on recent lung cancer findings involving CK2-dependent ECE-1c stabilization, this article outlines a translational strategy for connecting target engagement with clinically meaningful phenotypes.
-
hiPSC Intestinal Organoids for Pharmacokinetics
2026-09-01
Saito and colleagues established a direct 3D cluster-culture strategy for generating human iPSC-derived intestinal organoids with long-term expansion, differentiation capacity, and cryopreservation potential. The resulting intestinal epithelial cells displayed enterocyte-associated CYP and transporter activities, supporting a more human-relevant platform for oral drug absorption and metabolism studies.
-
Lithium, Exosomal Wnt10a, and Bone Regeneration
2026-08-31
The reference study shows that lithium enhances bone mesenchymal stem cell osteogenesis by promoting Rab11a- and Rab11FIP1-dependent secretion of exosomal Wnt10a, thereby activating β-catenin signaling in recipient cells. Its findings support exosome engineering and GelMA-based delivery as strategies for improving bone repair, while also identifying extracellular-vesicle release as a testable mechanistic variable.
-
MK-571: Bridging Leukotriene Biology and Translation
2026-08-31
A translational framework for using MK-571 (L-660,711) to separate cysteinyl leukotriene receptor biology from MRP1/ABCC1-mediated drug transport in inflammation and macrophage-protection studies.
-
ALDH2 Activation Delays Pressure-Overload Heart Failure
2026-08-30
The reference study identifies ALDH2 as more than an oxidative-stress defense enzyme: its activation extends the early postnatal proliferative window of mouse cardiomyocytes and promotes proliferation after pressure overload. In adult mice, pharmacological activation with Alda-1 delayed heart failure after transverse aortic constriction, supporting ALDH2 as a target for cardiac regeneration research while leaving the downstream cell-cycle mechanism and broader translational relevance to be established.
-
Cholecystokinin octapeptide ammonium: Lab Workflows
2026-08-29
Cholecystokinin octapeptide ammonium enables receptor-aware studies spanning neurobehavior, neuronal survival, immune signaling, and cardiac peptide secretion. This guide translates its sulfation-dependent biology into practical dose selection, zebrafish behavioral workflows, assay controls, and troubleshooting decisions.
-
(+)-Bicuculline: Protocol and QC Guide
2026-08-28
This guide provides practical handling, stock-preparation, storage, and assay-planning guidance for (+)-Bicuculline as a GABAA receptor antagonist in neuroscience research. It is intended for controlled laboratory studies only and should not be used for diagnostic, medical, or therapeutic applications.